GAZYVA (obinutuzumab) for Follicular Lymphoma - Cancer Therapy Advisor

GAZYVA (obinutuzumab) for Follicular Lymphoma

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews drug information for GAZYVA (obinutuzumab), indicated for follicular lymphoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 11: Use in Specific Populations
Slide 13: Clinical Pharmacology
Slide 17: Warnings and Precautions
Slide 23: Clinical Safety and Efficacy
Slide 28: Drug Storage and Supply
Slide 30: References